Table 2.

Distance moved during the CPP trials (±S.E.M.) Control: neurotypical/sham male Wistar rats receiving intraamygdaloid PBS (n = 8); VPA: intrauterine VPA-treated rats showing autistic-like behavior (n = 7); VPA + 10 ng OT: animals showing autistic-like behavior, microinjected with 10 ng OT (n = 7); VPA + D2 ANT + OT: animals with autistic-like behavior, animals microinjected with 10 ng OT and pretreated with 4 µg Sulpiride (n = 7); VPA + D2 ANT: animals with autistic-like behavior, treated with 4 µg Sulpiride (n = 7). For more explanation, see the text.

Distance Covered (cm/15 min) (Avg ± SEM)	Habituation	Avg. of Conditioning Trials	Test
control (n = 8)	6272.82 ± 502.11	4022.12 ± 283.19	5963.25 ± 501.05
VPA (n = 7)	6363.81 ± 468.52	3576.51 ± 291.13	5875.01 ± 485.26
VPA + 10 ng OT (n = 7)	6014.75 ± 456.99	3612.35 ± 285.87	5766.53 ± 446.38
VPA + D2 ANT + OT (n = 7)	6402.10 ± 535.84	3595.82 ± 299.16	5793.33 ± 495.12
VPA + D2 ANT (n = 7)	6248.34 ± 433.18	3375.99 ± 263.15	5569.68 ± 458.21